Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma

Saved in:
Bibliographic Details
Published in:Investigational new drugs 1991-02, Vol.9 (1), p.69-72
Main Authors: DHINGRA, H. M, MURPHY, W. K, WINN, R. J, RABER, M. N, WAUN KI HONG
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic - adverse effects
Antimetabolites, Antineoplastic - therapeutic use
Antineoplastic agents
Azacitidine - adverse effects
Azacitidine - analogs & derivatives
Azacitidine - therapeutic use
Biological and medical sciences
Drug Evaluation
Female
General aspects
Humans
Male
Medical sciences
Mesothelioma - drug therapy
Middle Aged
Pharmacology. Drug treatments
Pleural Neoplasms - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0167-6997
1573-0646
DOI:10.1007/BF00194548